Month: 2025-08

TransNusa Increases Flight Options For Two Routes From ManadoPT TransNusa Aviation Mandiri converts two chartered flights from Manado to scheduled commercial flightsTickets sale for Manado to Shanghai and Manado to Shenzhen started on July 29, 2025TransNusa continuously expands international route and starts strengthening Manado base in IndonesiaJAKARTA, Aug 11, 2025 - (ACN Newswire via SeaPRwire.com) - FOCUSING on organic growth, TransNusa converts two charter flight routes between Manado and Shanghai as well as Manado and Shenzhen to scheduled commercial routes, starting 8 September and 2 October, respectively.TransNusa Group Chief Executive Officer, Datuk Bernard Francis said while the Manado-Shenzhen scheduled commercial flight is direct, the Manado-Shanghai flight plan has a stop-over of between 30 to 35 minutes at the Clark International Airport.“Our main priority and focus is to create new exciting routes for our passengers and offer seamless and fast travels, whether through direct routes or transits routes.” Datuk Francis said, explaining that the Manado-Clark-Shenzhen route is very popular among tourists.“With the launch of these new commercial routes, we hope to provide tourists from Manado and China additional options to travel,” Datuk Francis said, adding that TransNusa will also provide its passengers with options to visit other major tourist destinations from Manado, such as Bali, also known as Indonesia’s Island of Gods.Details of the new RoutesFrom October 2, TransNusa will be operating three flights a week from Manado’s Sam Ratulangi International Airport to Shenzhen Bao’an International Airport. The TransNusa flight, 8B 175, will depart Manado at 21.10pm and arrive at the Shenzhen Bao’an International Airport at 01.00am while TransNusa flight, 8B 176, will depart Shenzhen Bao’an International Airport at 02.00am and arrive in Manado at 05.50am.TransNusa will be operating the Manado-Shenzhen route three times weekly. The Manado-Shenzhen route scheduled commercial flights are on Tuesday, Thursday and Saturday while the Shenzhen-Manado route scheduled commercial flights will be on Wednesday, Friday and Sunday.TransNusa’s scheduled Manado-Shenzhen flight ticket price starts from as low as IDR3.499.000, CNY1.525 and USD226 while it’s schedule flight from Manado to Shanghai ticket price starts from as low as IDR3.988.000, CNY1.688 and USD257. TransNusa tickets are available for purchase at transnusa.co.id and all other main online travel agent platforms worldwide.Meanwhile, the TransNusa flight, 8B 101, from Manado will depart at 14.00pm and arrive at the Clark International Airport at 16.40pm. The flight will depart Clark International Airport at 17.15pm and arrive at the Shanghai Pudong International Airport at 20.55pm. The flight, 8B 102, will depart the Shanghai Pudong International Airport at 23.05pm and arrive at Clark International Airport at 02.30am. The TransNusa 8B 102, will depart Clark International Airport at 03.00am and arrive at Manado’s Sam Ratulangi International Airport at 05.30am.Datuk Bernard said that TransNusa will operate the six hours 50 minutes scheduled commercial flight route 3 times week. TransNusa’s scheduled commercial flight from Manado will depart on Monday, Wednesday, and Friday.For both the newly introduced scheduled commercial flights, Datuk Bernard said TransNusa will be utilizing its C909 jet airliner, which has only 95 seats, to ensure that passengers travel with comfort.Datuk Bernard Francis…TransNusa offers new flight options for its passengersBrief History On TransNusaTransNusa, which had to close business due to the Covid-19 pandemic was injected with new shareholders and management team in 2022. The airline opened its doors for business in October and within six months, in April 2023, launched its first international flight from Jakarta to Kuala Lumpur, Malaysia.After which, under the new leadership of Datuk Francis, and the new management team, the airline successfully launched three more new international routes by the end of 2023. In 2024, the airline continued growing its international and domestic route and at the same time recording historical firsts that also became a significant industry first for the Indonesian aviation industry. Since April 2023, TransNusa has been making headlines in Malaysia, Singapore, China and around the world with news of being the first airline in Indonesia and the world to develop and introduce a new domestic route connecting Bali and diving haven, Manado. TransNusa also became the second Indonesian airline to receive approval to fly to China and provided Indonesians with more pricing and route options to China.TransNusa’s aggressive international growth strategy combined with its domestic business operations approach has enabled the airline to be the fastest growing airline in South East Asia.About TransNusaTransNusa Airline, is a Premium Service Carrier. After the take-over, in February 2024, the airline rebranded itself from being a Low-Cost Carrier to a Premium Service Carrier in line with its upgraded aircrafts that offers better comfort as well as based on the flexibility and quality of the services offered.TransNusa, which received its AOC certification on 9th September 2022, launch its first three A320 operations on 6th October, 14th October and 12th December, 2022. In 2023, TransNusa introduced a new business model making it the first Premium Service Carrier in the Asia Pacific region. TransNusa introduced its first international flight on 14th April, 2023. The airline is currently has bases in Jakarta, Bali and Manado.The airline currently flies from Jakarta to Yogyakarta, Bali, Kuala Lumpur, Malaysia, Subang, Malaysia and Guangzhou, China. It also flies from Bali to Jakarta and Manado. TransNusa will be launching its scheduled Bali to Perth route on March 20th and its Bali to Guangzhou route on April13th. TransNusa made history when it became the second Indonesian airline to fly to China and the first Indonesian airline to launch a Premium Service Carrier business model.Passengers can book their flights on the TransNusa website (www.transnusa.co.id), through authorized travel agents in Singapore, Malaysia and Indonesia, or by contacting the airline's customer service centre at, +62216310888. For the Singaporean market, passengers can contact TransNusa’s General Sales Agent, Chariot Travels Pte Ltd, at +65 86602719 for assistance.TransNusa’s Primary Media Contact:Trina Thomas Rajtrina@myqaseh.org+60124992672 (watsapp) Copyright 2025 ACN Newswire via SeaPRwire.com.

DUBAI, Aug 11, 2025 - (ACN Newswire via SeaPRwire.com) - 31 Concept (31C), an emerging leader in network intelligence and cybersecurity innovation, today announced it will unveil its first patent-pending technology at ISS Asia 2025 in Singapore. The breakthrough, developed entirely within the company's 31 Concept Research Lab, marks a major milestone for the startup, which is stepping out of stealth mode after just seven months of intense development.31 Concept's Innovation PatentedThe 31 Concept Research Lab serves as the company's innovation engine, uniting world-class experts in deep packet inspection, AI-driven analytics, cybersecurity, and advanced networking. With decades of combined experience from projects spanning telecom, military, and national infrastructure, the lab's team operates at the intersection of applied research and practical deployment, delivering solutions designed to solve real-world challenges at scale."Our patent-pending technology is the direct result of the unique expertise and relentless drive inside our Research Lab," said Misha Hanin, CEO and Co-Founder of 31C. "We built this in record time without compromising on quality or innovation. This is just the first step in a series of breakthroughs we intend to bring to the market."ISS Asia, recognized as one of the most important professional conferences in the world for intelligence, security, and law enforcement technologies, will provide the global stage for the debut. The event draws leaders from government, telecom, and private industry, making it the perfect venue for 31C's first public presentation."The speed at which the 31 Concept Research Lab turned a concept into a patent-pending reality shows the strength of our people and our process," added Boriss Heismann, CTO of 31C. "This is technology designed to address the most pressing needs in network visibility, security, and performance - and to do it in ways the industry has not seen before."The company's presentation at ISS Asia 2025 will highlight the capabilities of the new platform, detail the patent-pending elements, and outline the roadmap for further innovations currently in development.About 31C31 Concept is a technology company focused on next-generation data intelligence platforms for telecom providers, governments, and regulated industries. Its flagship R&D division, the 31 Concept Research Lab, develops breakthrough technologies in network intelligence, cybersecurity, and AI-driven analytics.Contact InformationMisha HaninCEOmisha.hanin@31c.ioSOURCE: 31 ConceptRelated Images Copyright 2025 ACN Newswire via SeaPRwire.com.

沙烏地阿拉伯利雅得, 2025年8月11日 - (亞太商訊 via SeaPRwire.com) - 沙烏地電力公司（SEC）在2025年第二季及上半年持續展現穩健的財務與營運表現。第二季營收成長24%，達到277億沙烏地里亞爾，毛利上升42%，達到74億里亞爾。營業利潤增加21%，達到68億里亞爾；淨利達到53億里亞爾，較去年同期成長22%。在2025年上半年，沙烏地電力公司（SEC）報告營收成長23%，總額達472億沙烏地里亞爾。毛利上升40%，達102億里亞爾；營業利潤增加20%，達91億里亞爾；淨利較2024年同期成長19%，達63億里亞爾。此強勁財務表現主要受益於受管制資產基礎擴張所帶來的可允許收入增加，以及因應能源需求上升而提升的電力生產收入。上述收益部分被網路擴建、資產增加與負載上升所導致的營運與維護成本上升所抵銷，同時還包括應收帳款撥備增加及其他收入減少的影響。SEC指出，其受管制資產基礎的擴張，反映出輸電與配電網路持續成長，以滿足不斷增加的電力需求、支援再生能源併網，以及推進能源儲存專案。公司同時也持續在數位轉型與營運卓越計畫上進行策略性投資。對業績發表評論時，沙烏地電力公司代理執行長哈立德·賓·薩利姆·阿勒加姆迪工程師表示：「2025年上半年的良好表現，反映了公司在業務組合與資產基礎上的持續成長，這與我們的策略一致，即在全國範圍內提供可靠且安全的電力、提升客戶的服務品質，並推進永續發展與營運卓越。我們致力於進一步強化公司的市場地位，並把握沙烏地阿拉伯能源轉型所帶來的重大機遇，這與『2030願景』的宏大目標相契合——而這一切都得益於我們優秀本國員工的奉獻精神，以及我們為國家服務的堅定承諾。」截至2025年上半年末，併入電網的再生能源裝置容量已超過9.2吉瓦，公司並在比沙、賈贊、海米斯穆塞特及納季蘭四個地點，成功啟用總計8.0吉瓦時的電池儲能系統。沙烏地電力公司目前正開發額外14吉瓦時的儲能容量，預計將於明年投入運行並併入電網，進一步強化電網的可靠性與再生能源的整合能力。為重申在營運全程中落實永續發展並提升其ESG（環境、社會與公司治理）實踐的承諾，SEC於2025年在標普全球（S&P Global）的ESG評級中取得顯著躍升，獲得100分中的65分，較2024年提升30%，較2023年更大幅提升85%。此成就使SEC位居沙烏地阿拉伯所有企業之首，並成為中東與北非能源產業的區域領導者，其表現超越全球公用事業產業平均水準66%，進一步鞏固其在永續績效方面的全球領先地位。2025年上半年，電力需求持續上升，尖峰負載成長3%，達到75.1吉瓦，總用電量增加10%，達到1,605億度。於1446年回曆朝覲季期間，SEC在麥加、麥地那及聖地成功應對創紀錄的尖峰負載，且未發生任何服務中斷，這得益於公司全面動員資源，為朝覲者提供服務並確保其舒適。公司在服務擴展與基礎設施建設方面亦取得重大進展。SEC新增連接約11萬名新用戶，將總用戶數提升至1,140萬。配電網路長度成長6%，超過82.7萬迴路公里；輸電網路與光纖網路則分別成長6%與9%，達到103,800與101,000迴路公里。作為提升服務可靠性與客戶體驗的一部分，SEC持續升級數位基礎設施並自動化配電變電站，並透過光纖網路將其連接至控制中心。配電變電站自動化率已達38.4%，客戶滿意度提升至85.8%，顯示服務品質與溝通成效均有所改善。聯絡資訊Saudi Electricity Company (SEC) Saudi Electricity Company (SEC)Media Relations Departmentalkahrabacare@se.com.saUnified Call Center: 920000222來源: Saudi Electricity Company (SEC) Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月11日 - (亞太商訊 via SeaPRwire.com) - 專注於微創介入冷凍治療領域的創新醫療器械公司康灃生物科技（上海）股份有限公司（「康灃生物」或「公司」，股份代號：6922.HK）公布其截至2025年6月30日止六個月的中期業績。報告期內，公司展現出強勁的增長動能與顯著的經營優化，核心財務指標表現亮眼，特別是其呼吸介入產品線實現爆發式增長，標誌着公司商業化進程步入快車道。呼吸介入產品成業績增長核心引擎，全球領先優勢凸顯公告顯示，2025年6月30日止六個月，康灃生物實現收入達人民幣5,111萬元，較2024年同期1,948萬元激增162.4%，創下歷史同期新高。這一增長主要源於公司在呼吸介入領域的戰略性布局迎來收穫期：公司2025年3月獲國家藥監局批准的惡性狹窄冷凍消融系統及此前上市的冷凍粘連治療系統等呼吸介入產品銷量迅猛增長，成為驅動收入增長的絕對主力；同時，公司與國際醫療巨頭波士頓科學的中國附屬公司波科國際醫療貿易（上海）有限公司(「波科」)在其他呼吸介入產品的中國大陸的經銷合作也貢獻了可觀的增量收入。更值得一提的是，公司的哮喘冷凍消融系統獲得美國食品及藥物管理局授予的「突破性醫療器械」認證 ，成為中國企業在呼吸介入冷凍治療領域首個獲此國際權威認證的產品，為進軍全球醫療市場奠定基礎。康灃生物在呼吸介入領域構建了極具競爭力的產品矩陣，覆蓋從惡性狹窄、良性狹窄、哮喘、慢阻肺（COPD）、肺周結節、慢性咳嗽到氣道結核等多種重要適應症。其中：惡性狹窄冷凍消融系統已在中國成功商業化；哮喘、慢阻肺系統處於確證性臨床試驗階段，預計2026年獲批；咳嗽、結核、肺周結節等系統也處於不同研發階段；冷凍粘連治療系統含一次性冷凍探頭及可重複使用冷凍探頭已獲批准並上市。這些產品的成功，主要建立在康灃兩大核心技術平台之上--獨特的液氮冷凍消融技術（以液氮為冷媒能量源）和先進的柔性導管技術。該平台提供了深低溫、精確控制、微創介入的能力，在治療效率和安全性上具有顯著優勢，形成了競爭對手難以逾越的技術壁壘。平台價值裂變，多領域布局加速商業化康灃生物的核心價值不僅在於其亮眼的呼吸介入管線，更在於其作為創新型冷凍治療平台企業的稀缺屬性。公司以液氮冷凍技術和柔性導管技術為基石，成功將產品線拓展至多個龐大的治療領域：其中，在血管介入領域：心臟冷凍消融系統（用於房顫治療）已於2024年9月在中國商業化。Cryofocus冷凍消融系統（用於高血壓治療）獲美國食品及藥物管理局「突破性器械」認定，處於確證性臨床階段。肺動脈高壓冷凍消融系統處於臨床前研階段。這些產品涉及的心血管適應症市場空間巨大。在經自然腔道內鏡手術（NOTES）領域：呼吸介入領域如前所述，產品線豐富且領先。腫瘤介入領域如膀胱冷凍消融系統已在中國上市；胃部冷凍消融系統、食道冷凍噴霧治療系統處於臨床試驗階段，瞄準胃癌、食道癌等市場。在非冷凍治療產品方面：如肺結節定位針（已上市）、內鏡吻合夾（已上市）、房顫脈衝電場消融（PFA）系統、抗胃食管反流系統等，形成互補和協同。這種「一平台、多賽道」模式，賦予了康灃生物極強的適應症擴展能力和管線可持續性。公司目前擁有14款冷凍治療產品及在研產品，加上9款非冷凍產品，總計23款產品組成的強大管線庫，其中11款已實現商業化。這種平台化的布局在專注於單一領域的醫療器械公司中極為罕見，展現了巨大的長期增長潛力和抗風險能力。財務表現優異，成長動能持續除了呼吸介入產品所驅動的收入的高增長，康灃生物中期業績還透露出積極的持續成長信號。報告期內，公司技術平台的優勢進一步轉化為財務韌性。2025年6月30日止六個月，康灃生物毛利達3,431萬元，同比增長124.5%；毛利率保持在穩健的67.1%。研發效率提升，虧損顯著改善。數據顯示其研發開支優化至1,791萬元（同比下降51.9%），期內虧損收窄至2,722萬元，同比縮減51.4%，扭虧趨勢明確。現金儲備較2024年底增長40.1%至6,368萬元，為持續研發和市場拓展提供堅實後盾。隨着更多自研高價值產品（如惡性狹窄冷凍消融系統）的上市和放量，以及波科經銷合作的深化，公司收入來源更加多元化且質量提升。報告期內，研發費用的大幅下降並非削減投入，而是研發效率提升和部分產品進入後期階段（減少耗材投入）的結果，員工成本優化和管理改進是關鍵原因。這為公司未來在維持高強度創新的同時控制成本提供了良好範式。此外，公司在銷售網絡建設投入也在加大，報告期內銷售及分銷開支同比增加174.4%至916萬元，反映了公司積極投入資源搭建營銷團隊和推廣新上市產品（如惡性狹窄冷凍消融系統），為未來銷售規模的進一步擴大奠定基礎。對標全球龍頭，估值窪地顯現康灃生物在呼吸介入冷凍治療，特別是在獲得FDA突破性認證的哮喘治療等呼吸介入領域的技術實力，使其具備了與國際領先企業同台競技的潛力。以專注於阻塞性睡眠呼吸暫停（OSA）治療的神經刺激器企業Inspire Medical Systems（INSP）作為參照（雖然適應症不完全相同，但同屬呼吸系統神經介入器械領域）： Inspire Medical目前市值22.79億美元，市盈率（TTM）44.28倍（根據8月7日收盤價）。康灃生物的哮喘冷凍消融系統同樣作用於肺部迷走神經（靶向神經）消融，以微創介入方式治療哮喘，其技術路徑具有創新性且獲得了美國食品及藥物管理局的突破性認可。然而，作為一家覆蓋多領域、擁有豐富管線、且多個產品已商業化的平台型創新公司，康灃生物當前在港股的估值（INSP市值為康灃生物的12.8倍）遠低於Inspire Medical的估值水平。這種巨大的估值差異，固然有市場（美股vs港股）、發展階段（Inspire已盈利且在美國市場成熟）、單一產品vs平台等因素的影響，但也清晰地凸顯出康灃生物當前市值與其技術實力、產品管線廣度和全球化突破潛力相比，存在顯着的提升空間。隨着其呼吸介入產品（尤其是是哮喘冷凍消融系統、慢阻肺冷凍噴霧治療系統、肺周結節冷凍消融系統）臨床進展推進、海外註冊路徑明確以及收入規模的持續高速增長，市場對其價值的重估將是一個大概率事件。當前的估值水平，對於看好微創介入冷凍治療賽道長期前景和平台型企業價值的投資者而言，提供了一個具有吸引力的布局窗口。展望未來，康灃生物的戰略清晰，包括迅速推動在研產品的臨床開發和商業化；專注於微創介入冷凍治療，基於技術平台進一步擴大產品組合；持續研發各種底層技術及配套技術；及選擇性地拓展全球業務。公司正穩步從研發驅動向研發與商業化雙輪驅動轉型，並朝着成為「全球微創介入冷凍治療醫療器械平台」的願景堅實邁進。 Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年8月11日 - (亞太商訊 via SeaPRwire.com) - 8月8日，全國首批數據中心REITs--南方潤澤科技數據中心REIT與南方萬國數據中心REIT正式登陸滬深交易所，上市首日雙雙漲停，分別報收5.850元和3.9元。兩單產品的亮眼表現，不僅標誌著REITs市場正式切入「科技新基建」賽道，也凸顯了產業資本在推動算力基礎設施證券化中的重要作用。作為兩單項目的重要投資方，港股上市公司首程控股（0697.HK）再次站在市場關注的風口。通過全資子公司北京首源欣榮投資有限公司，以及旗下管理的北京平準基礎設施不動產股權投資基金，首程控股分別投資了南方萬國數據中心REIT與南方潤澤科技數據中心REIT。這不僅是公司在數據中心領域的又一次精準布局，更是其深耕REITs市場戰略版圖的最新落子。一、切入「算力底座」，緊抓數字經濟新機遇公開資料顯示，南方萬國數據中心REIT的底層資產為位於昆山花橋的國金數據雲計算數據中心，機櫃數4192個；南方潤澤科技數據中心REIT的底層資產則為位於京津冀國家算力樞紐節點的潤澤（廊坊）國際信息港A-18數據中心，機櫃數5897個，上架率超99%。兩大項目均屬於區域核心算力資源，在支撐5G、人工智能、大數據等應用方面具有不可替代的戰略價值。業內人士指出，數據中心REITs的推出，意味著公募REITs資產類型首次覆蓋到科技創新基礎設施領域，有助於推動算力資源高效配置，提升資本市場服務數字經濟的能力。二、全鏈條布局，構建REITs生態閉環事實上，首程控股在REITs領域的布局早已形成全鏈條覆蓋。自2021年作為首批公募REITs的最大戰略投資者之一，公司便圍繞「Pre-REITs產業基金培育-平台運營管理-公募REITs退出-戰略配售投資」建立了完整的生態體系。截至目前，首程控股REITs基金管理規模已突破300億元，投資領域覆蓋交通樞紐、城市更新、綠色能源、數據中心等多個板塊。今年以來，公司相繼投資了首農產業園REIT、華夏華電清潔能源REIT，並通過北京平準基金與國壽投資、財信人壽等機構合作，設立目標規模100億元的平準基礎設施基金，進一步夯實其在REITs市場的產業資本地位。三、產業資本優勢顯現，助力市場良性發展作為產業資本，首程控股不僅提供資金，更依託自身在智能基礎設施資產管理、運營、整合等方面的能力，為底層資產的運營效率和長期價值提升提供保障。這種「資金+運營」的雙重賦能模式，使公司在REITs市場中形成了與單純財務投資機構的差異化優勢。分析人士認為，隨著公募REITs市場規模的不斷擴容，以及數據中心等新型基礎設施的證券化步伐加快，首程控股有望在「科技新基建+REITs」這一新興交匯賽道上持續受益，並鞏固其在行業內的引領地位。Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 亞太商訊 via SeaPRwire.com.